Corgi ONTO 2x Daily 

$16.52
123
-$1.21-6.82% Monday 19:31
-$0.17-1.05%Monday 20:00After hours

Statistics

Day High
16.42
Day Low
15.44
52W High
43.14
52W Low
10.62
Volume
2,353
Avg. Volume
11,785
Mkt Cap
253.88M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Expense Ratio

0.45%
0%
1%+
The annual fee that you pay to the fund company for managing your investment. The lower the expense ratio, the better. This is not an investment recommendation.

Earnings

12NovExpected
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q1 2026
Q2 2026
Next
-0.56
-0.43
-0.29
-0.16
Expected EPS
-0.205
Actual EPS
N/A

Financials

328.67%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
2.79MRevenue
9.17MNet Income

Analyst Ratings

1.00Average Price Target
The highest estimate is 1.00.
From 2 ratings within the last 6 months. This is not an investment recommendation.
Buy
0%
Hold
100%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ONTX. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Gilead Sciences
GILD
Mkt Cap181.18B
Gilead Sciences is a biopharmaceutical company that develops drugs for cancer, a direct competition to Onconova's focus on cancer therapeutics.
AMGEN
AMGN
Mkt Cap237.52B
Amgen focuses on human therapeutics, including treatments for cancer, making it a competitor in the oncology space.
Bristol-Myers Squibb
BMY
Mkt Cap136.88B
Bristol Myers Squibb is involved in discovering, developing, and delivering innovative medicines for cancer, directly competing with Onconova's cancer therapy research.
Pfizer
PFE
Mkt Cap159.99B
Pfizer develops and produces medicines and vaccines for a wide range of medical disciplines, including oncology, competing in the cancer treatment market.
Merck
MRK
Mkt Cap376.37B
Merck is known for its cancer drugs and vaccines, making it a competitor in the oncology sector.
Novartis
NVS
Mkt Cap301.95B
Novartis focuses on patented medicines for a range of diseases, including cancer, competing with Onconova's therapeutic developments.
Abbvie
ABBV
Mkt Cap468.22B
AbbVie operates in the pharmaceuticals sector, focusing on oncology, among other areas, making it a competitor.
Astrazeneca
AZN
Mkt Cap257.42B
AstraZeneca operates in the biopharmaceutical sector, focusing on the development of cancer drugs, directly competing with Onconova.
Lilly(Eli) &
LLY
Mkt Cap1.12T
Eli Lilly and Company develops a wide range of pharmaceutical products, including cancer treatments, making it a competitor.
Regeneron Pharmaceuticals
REGN
Mkt Cap85.87B
Regeneron Pharmaceuticals focuses on developing medicines for serious medical conditions, including cancer, competing in the same space as Onconova.

Holdings

About

Traws Pharma Inc is a clinical-stage biopharmaceutical company dedicated to developing novel therapies to target critical threats to human health in respiratory viral diseases. It is advancing novel investigational antiviral agents that have potent activity against difficult-to-treat or resistant virus strains that threaten human health. Its product candidates are Tivoxavir marboxil, Ratutrelvir, and Narazaciclib. The company has four clinical programs: (i) tivoxavir marboxil, (ii) ratutrelvir, (iii) narazaciclib (ON 123300), and (iv) rigosertib. It is focused on the development of tivoxavir marboxil and ratutrelvir. The company derives revenue from its collaboration and licensing agreements.
Show more...
CEO
Iain D. Dukes
Employees
7
Country
United States
ISIN
US21874K7404
WKN
000A40PJ7

Listings

0 Comments

Share your thoughts

FAQ

What is Corgi ONTO 2x Daily stock price today?
The current price of ONTX is $16.52 USD — it has decreased by -6.82% in the past 24 hours. Watch Corgi ONTO 2x Daily stock price performance more closely on the chart.
What is Corgi ONTO 2x Daily stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on BATS exchange Corgi ONTO 2x Daily stocks are traded under the ticker ONTX.
What is Corgi ONTO 2x Daily market cap?
Today Corgi ONTO 2x Daily has the market capitalization of 253.88M
When is the next Corgi ONTO 2x Daily earnings date?
Corgi ONTO 2x Daily is going to release the next earnings report on November 12, 2026.
What were Corgi ONTO 2x Daily earnings last quarter?
ONTX earnings for the last quarter are -0.16 USD per share, whereas the estimation was -0.34 USD resulting in a +52.24% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Corgi ONTO 2x Daily revenue for the last year?
Corgi ONTO 2x Daily revenue for the last year amounts to 2.79M USD.
What is Corgi ONTO 2x Daily net income for the last year?
ONTX net income for the last year is 9.17M USD.
How many employees does Corgi ONTO 2x Daily have?
As of August 25, 2026, the company has 7 employees.
In which sector is Corgi ONTO 2x Daily located?
Corgi ONTO 2x Daily operates in the Health & Wellness sector.
When did Corgi ONTO 2x Daily complete a stock split?
The last stock split for Corgi ONTO 2x Daily was on September 23, 2024 with a ratio of 1:25.
Where is Corgi ONTO 2x Daily headquartered?
Corgi ONTO 2x Daily is headquartered in NEWTOWN, United States.